EN DE
Watch New York Times Company for free: we tell you when fair value or trend changes.
Data-driven stock valuation

New York Times Company (NYT) fair value: what the stock is really worth

As of Nov 5, 2026: fair value (intrinsic value) of New York Times Company stock $42.10, price $65.57, that is 35.8% below the price, quality 80 out of 100. Rating: strongly overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Communication Services US

NY New York Times Company logo Broad data Nov 6, 2026

New York Times Company

NYT · US
Strong quality, but very expensive

Our calculation puts a fair price 36% below what the stock costs today.

Quality 80/100
Healthy Growth (revenue 5y +9.6 %/yr in USD)
Solidly profitable · 13.5% net margin (TTM)
Low debt
Generates free cash flow
1.3% dividend yield · Well covered
Wide moat 77/100
Broad data
Mixed vs. peers (7/15)
Insiders sold $2.1M (6M)
Fair value $42.10 · Strongly overvalued (−35.8%)
Downbeat coverage

Risks from the AI analysis

🚩Generative AI could replace news access

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$85.28 $26.49 Fair Value $42.10 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

60‑month range $26.49 – $85.28 · fair‑value band $31.90 – $52.30 · the $65.57 price screens above the $42.10 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow New York Times in your weekly email

Every Wednesday you see whether New York Times is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

The New York Times Company, together with its subsidiaries, creates, collects, and distributes news and information worldwide. It operates through two segments, The New York Times Group and The Athletic.

Show moreShow less

It offers The New York Times (The Times) through company's mobile application, website, printed newspaper, and associated content, such as podcast. The company offers The Athletic, a sports media product; Cooking, a recipe product; Games, a puzzle games product; and Audio, an audio product.

In addition, the company offers a portfolio of advertising products and services to advertisers, such as luxury goods, technology, and financial companies, to promote products, services or brands on digital platforms in the form of display ads, audio and video, in print in the form of column-inch ads, and at live events; and Wirecutter, a product review and recommendation product.

Further, the company licenses content to digital aggregators in the business, professional, academic and library markets, and third-party digital platforms; articles, graphics, and photographs, including newspapers, magazines, and websites; and for use in television, films, and books, as well as provide rights to reprint articles, and create and sell new digests.

Additionally, the company engages in commercial printing and distribution for third parties; and operates the NYTimes.com website. The company was founded in 1851 and is headquartered in New York, New York.

Stock analysis

New York Times Company (NYT) currently trades at $65.57, while our model-based Fair Value estimate is $42.10, 36% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $43.46 per share, and 0 of the 24 models we run sit above the $65.57 price.

Bear case: the Dividend Discount group reads lowest at $8.03, and 24 of the 24 models stay below the price. Data coverage for this calculation is high.

Scenario range: $31.90 (bear) to $52.30 (bull), the price of $65.57 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 80/100 (high quality), in the Communication Services sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

New York Times Company reported revenue of $2.8B in FY2025 versus $2.1B in FY2021, a compound +8.0%/yr. Reported net income was $344M in FY2025, compounding +11.8%/yr from FY2021.

Key figures

Market cap $10.7B Large · P/E ratio 26.1 · P/S ratio 3.54 · EPS (TTM) $2.50 · Dividend yield 1.3% · Net margin 13.5% · Return on equity 19.7% · Return on assets (EBIT) 11.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 77 out of 100 (medium confidence).

What moves the price

The share trades about 23% below its 52-week high and 15% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Communication Services peers we cover trades at −3% fair-value upside, at −36%, NYT screens richer than that median.

Fair Value models

Bear $31.90 Fair Value $42.10 Bull $52.30
Price $65.57 · Downside -35.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($1.38 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $36.65 $49.33 $73.64 80
Growth DCF $38.05 $50.43 $72.31 79
Owner Earnings $32.17 $43.24 $64.44 76
All 24 models by family
DCF Models
FCF DCF $36.65 $49.33 $73.64 80
Owner Earnings $32.17 $43.24 $64.44 76
5Y Revenue Exit $29.50 $40.72 $57.05 73
5Y EBITDA Exit $31.25 $43.70 $60.21 76
5Y P/E Exit $33.82 $48.09 $65.12 71
10Y Revenue Exit $31.23 $41.48 $53.06 68
10Y EBITDA Exit $33.01 $43.46 $55.15 70
10Y P/E Exit $34.60 $46.37 $58.39 65
Earnings-Based
Graham-Dodd $14.57 $24.94 $30.46 67
EPV $22.14 $25.60 $28.64 74
Dividend Discount
Gordon GGM $6.36 $8.03 $9.76 69
DDM Multi-Stage $6.36 $8.61 $11.38 67
Multiples
P/E Multiple $35.36 $47.15 $58.94 63
P/S Multiple $27.33 $36.43 $45.54 58
P/B Multiple $22.94 $30.59 $38.24 55
EV/EBIT $34.98 $46.22 $57.45 66
EV/EBITDA $31.90 $42.10 $52.30 67
EV/Revenue $26.84 $37.79 $48.74 54
Asset-Based
NCAV (Graham) $0.3000 $0.4500 $0.5600 55
Growth DCF
Growth DCF $38.05 $50.43 $72.31 79
Rev-Margin DCF $29.50 $41.37 $56.33 73
Economic Profit
Residual Income $13.84 $16.74 $22.73 76
ROIC Compounder $22.53 $26.63 $31.06 72
Growth Earnings
Growth-Adj P/E $24.93 $35.61 $46.29 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 80/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 69
How much profit the company makes from its sales and capital
Quality Growth 60
Are margins and returns getting better?
Cashflow 83
Do the profits arrive as real cash?
Financial strength 85
Debt, balance sheet and risk of trouble
Investment 76
Does it invest with discipline instead of growing at any price?
Low Volatility 67
How calm the share price moves, does not count
Price momentum 40
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 40
Distance to the 52-week high, does not count
New shares 90
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, 4 officers or directors sold shares worth $2.1M and none bought.

  • SaleJacqueline M WelchEVP and CHRO4,000 shares at $74.14$296,560Jun 3, 2026
  • SaleLevien Meredith A. KopitPRESIDENT & CEO, Director3× since Nov 6, 2025: 78,671 shares, avg. $75.17$5.9MMay 12, 2026
  • SaleWilliam BardeenEVP, Chief Financial Officer2× since Mar 3, 2026: 17,121 shares, avg. $79.15$1.4MMay 12, 2026
  • SaleDavid S. PerpichDirector9,000 shares at $77.06$693,540May 11, 2026
  • SaleArthur G. SulzbergerChairman and Publisher, Director13,000 shares at $79.95$1.0MMar 3, 2026
  • SaleDiane BraytonEVP, CHIEF LEGAL OFFICER4,600 shares at $77.03$354,338Feb 20, 2026
  • SaleR Anthony BentenSVP, Treasurer & CAO1,913 shares at $73.57$140,739Feb 17, 2026

Plus 23 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 5, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+9.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.6%
Start year 2020 (pandemic). Over 10 years: +6.0% a year
Revenue growth 40 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.8%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+16.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+15.2%
Dividend (yield on the price)1.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.base effect: 20.1% / 26.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.10% → 16%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Price in line with expectations
The price assumes less growth than the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+6.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+7.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +3.8% a year for the price and +4.5% for the forecasts.
Forecast 2026 (sales)+10.1%
Forecast 2027 (sales)+7.2%
Projected 2028 (sales)+6.6%
Projected 2029 (sales)+5.9%
Projected 2030 (sales)+5.3%

NYT screens overvalued: fair value 36% below the price. Compare with Xinhua Winshare Publishing and Media Co →

Recent news

News mood ⓘNews mood, the average tone of recent news (98 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Very negative
Recent news coverage is unusually downbeat.
Note from the team Oct 11, 2026
AI conclusion: The business draws a moderate moat from its brand strength and digital subscription model, yet family governance and thin innovation signals remain its chief constraints.
Main risk: Generative AI tools from OpenAI, Microsoft and others could summarize or answer queries with NYT content without driving traffic or paying licensing fees and thereby reduce digital subscriptions and ad revenue.
Bull case: The company could secure broad licensing agreements with AI firms and integrate AI tools to enhance its own reporting and subscriber experience, strengthening its premium position.
Bear case: If AI products continue to siphon audiences without compensation, the company could face sustained traffic and subscription declines that undermine its digital growth model.
The New York Times has shifted successfully toward digital subscriptions as its main growth driver. Its archive of high-quality content now draws legal challenges from AI firms that want it for training data. Will the company secure new licensing revenue streams or face prolonged disputes that tie up resources?
Join the discussion →

Compare New York Times Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Publishing · 98 stocks

Beats the industry median on 6/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 80 · Top 25%
Fair Value upside −35.8% · Bottom 25%
Profitability
Return on equity (12 months) 19.7% · Top 25%
Return on assets 11.5% · Top 25%
Net margin (12 months) 13.5% · Top 25%
Operating margin (12 months) 15.9% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 10.7% · Top 25%
Dividend yield (12 months) 1.3% · Bottom 25%

Valuation Multiplesvs Publishing median · lower = cheaper

P/E (12 months) 26.1× · Priciest 25%
P/B 5.24× · Priciest 25%
P/S (12 months) 3.54× · Priciest 25%
Price / free cash flow (fiscal year) 19.4× · Pricier than median
EV/EBITDA 18.0× · Priciest 25%
PEG 3.79× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 50
FUTURE (revenue growth)54 · sector 0
PAST (return on equity)79 · sector 26
HEALTH (low debt)100 · sector 99
DIVIDEND (yield)27 · sector 59

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Publishing stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Communication Services stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

New York Times Company: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "New York Times Company Fair Value". https://www.fairvalue-calculator.com/stock/NYT

Frequently asked questions

Is New York Times Company (NYT) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $42.10 versus a price of $65.57, about 36% lower (overvalued).
What is the fair value of NYT?
Our model-based fair value for New York Times Company is $42.10 (as of Nov 6, 2026), built from audited fundamentals. The current price: $65.57.
What is the quality score of NYT?
New York Times Company has a Quality Score of 80/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for New York Times Company (NYT)?
Our model-based price target is the fair value of $42.10 (as of Nov 6, 2026) from 24 valuation models. Cautious scenario $31.90, optimistic scenario $52.30. It is a calculation from audited fundamentals, not an analyst target.
What is the New York Times Company stock forecast for 2026?
Our models put fair value at $42.10, about 36% lower versus a price of $65.57 (overvalued). Cautious scenario $31.90, optimistic scenario $52.30. The calculation is refreshed regularly with new filings.
What is the revenue of New York Times Company (NYT)?
New York Times Company reported trailing-twelve-month revenue of about $3.0B (latest available figure, as of Nov 6, 2026).
Does New York Times Company pay a dividend?
New York Times Company currently shows a dividend yield of 1.33% relative to its recent price (as of Nov 6, 2026).
What growth is priced into New York Times Company (NYT)?
For today's price to be fair in a discounted-cash-flow model, New York Times Company would have to grow free cash flow by +6.2 % per year for five years (discount rate 8.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.6 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of NYT use?
Our models discount New York Times Company at 8.9 %: a base by market capitalisation (large), damped by beta 0.86, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For New York Times Company that is +6.2 % per year a year over ten years, using the same discount rate (8.9 %) and the same formula as our fair value.
How much growth has New York Times Company (NYT) delivered so far?
Over the past 5 years revenue at New York Times Company grew +9.6 % a year. The price currently implies +6.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of New York Times Company (NYT) growing?
The median revenue growth in the sector is +3.8 % a year. That is the yardstick for the growth priced into New York Times Company (+6.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of New York Times Company (NYT)?
The free-cash-flow yield on the price is 5.15 %: that much free cash flow New York Times Company produces per unit of market value. When it exceeds the discount rate of our models (8.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of New York Times Company (NYT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For New York Times Company it is $42.10 per share (as of Nov 6, 2026), against a price of $65.57. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is New York Times Company stock overvalued or undervalued in 2026?
As of Nov 6, 2026, NYT trades above its calculated fair value: price $65.57, fair value $42.10, a gap of about −36% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NYT?
No. The price is what the market pays today ($65.57); the fair value is what the company's own numbers justify ($42.10). For New York Times Company the two are $23.47 per share apart. That gap is exactly why we show both numbers side by side.
How much is New York Times Company worth?
The market values New York Times Company at about $10.7B (market capitalisation, as of Nov 6, 2026). Per share that is $65.57; our models calculate a fair value of $42.10 per share.
What do the bullish and bearish scenarios say about NYT?
Our models span a range for New York Times Company: cautious scenario $31.90, base $42.10, optimistic $52.30 per share (as of Nov 6, 2026, price $65.57). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of NYT?
New York Times Company trades at a price-to-earnings ratio of 26.1 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $42.10 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings, 5 of the years ex one-offs: 33.4. Other multiples: PEG 3.8, P/B 5.2, P/S 3.5, EV/EBITDA 18.0.
What is the PEG ratio of NYT?
The PEG ratio of New York Times Company is 3.79 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of New York Times Company (NYT)?
Balance-sheet figures for New York Times Company (as of Nov 6, 2026): return on equity 19.7%. They feed the Quality Score of 80/100, which measures business quality independently of the share price.
How far is NYT from its 52-week high?
New York Times Company trades at $65.57, about 23% below its 52-week high of $85.28 and 15% above the low of $56.92 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of $42.10 is for.
Which stocks are comparable to New York Times Company?
From the same area (Communication Services) we also value Xinhua Winshare Publishing and Media Co, Jiangsu Phoenix Publishing & Media Corporation, China Science Publishing & Media Ltd, China South Publishing & Media Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is New York Times Company stock attractive at the current price?
The data as of Nov 6, 2026: price $65.57, calculated fair value $42.10 (−36%), Quality Score 80/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NYT calculated?
We run New York Times Company through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $42.10, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. New York Times Company itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of New York Times Company (NYT)?
The closing price on Nov 5, 2026 was $65.57. Our model-based fair value is $42.10, about 36% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with New York Times Company right now?
A high-quality business (quality 80/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case ($52.30). The favourable scenario is already priced in.
Where does the earnings growth of New York Times Company (NYT) come from?
Earnings per share at New York Times Company grew +23.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +5.6 %, EBIT margin +7.4 %, tax rate −0.3 %, residual (interest, one-offs) +9.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of New York Times Company

How large is the market capitalisation of New York Times Company (NYT)?
The market capitalisation of New York Times Company is $10.7B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of New York Times Company (NYT)?
The price-to-sales ratio of New York Times Company is 3.54 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of New York Times Company (NYT)?
Earnings per share at New York Times Company are $2.50 (price ÷ EPS = P/E 26.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of New York Times Company (NYT)?
The dividend yield of New York Times Company is 1.3% (payout 34.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of New York Times Company (NYT)?
The net margin of New York Times Company is 13.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of New York Times Company (NYT)?
The return on equity (ROE) of New York Times Company is 19.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of New York Times Company (NYT)?
On an EBIT basis the return on assets of New York Times Company is 11.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of New York Times Company (NYT)?
The operating margin of New York Times Company is 15.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at New York Times Company (NYT)?
Revenue at New York Times Company is growing +10.7% versus a year earlier (3y avg +7.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at New York Times Company (NYT)?
Earnings per share at New York Times Company are growing +20.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does New York Times Company (NYT) hold?
New York Times Company holds more cash than debt, $207M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch New York Times Company in the live analysis

One click puts New York Times Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.